According to Bloomberg, in order to prevent a sales ban in the United States, Apple will be taking away a feature that measures blood oxygen levels from two of its watch models.
Late last year, Apple halted sales
Apple has been involved in a patent disagreement with Masimo, a company that produces pulse oximeters, for several years. The argument has resulted in the removal of its Series 9 and Watch Ultra 2 models from the market. These devices are used to measure the oxygen saturation in an individual’s red blood cells, which is an important indicator of overall health. The Cleveland Clinic has stated that low levels of blood oxygen can cause significant health issues, such as damage to the brain, heart, and other organs.
Apple pulled the watches from store shelves after the International Trade Commission (ITC) ruled that the watches’ blood oxygen sensors violated Masimo’s patents. The devices were banned on December 26. Apple appealed the decision and the ban was paused, allowing the tech giant to
Review sales of watches in the United States.